Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Taken from Ihub snoop
View:
Post by Trippedstocks on Dec 10, 2020 10:44pm

Taken from Ihub snoop

December 10, 2020 Notice Declaring Intention to be Qualified under National Instrument 44-101 (NI 44-101) Short Form Prospectus Distributions To: Ontario Securities Commission And To: British Columbia Securities Commission Alberta Securities Commission Revive Therapeutics Ltd. (the Issuer) intends to be qualified to file a short form prospectus under NI 44- 101. The Issuer acknowledges that it must satisfy all applicable qualification criteria prior to filing a preliminary short form prospectus. This notice does not evidence the Issuers intent to file a short form prospectus, to enter into any particular financing or transaction or to become a reporting issuer in any jurisdiction. This notice will remain in effect until withdrawn by the Issuer. Revive Therapeutics Ltd. Michael Frank Michael Frank Chief Executive Officer Copy and paste from sedar
Comment by Urrtoast on Dec 10, 2020 11:18pm
TrippedStocks .. can u tell me what this means please.. I don't really understand it . Thanks
Comment by 1ottrunner on Dec 11, 2020 6:11am
It means the company is looking to raise capital.
Comment by DeadPool007 on Dec 11, 2020 6:58am
It was posted yesterday morning around 9am on sedar. Market knows about it already. Wondering what the funds are for? Maybe preparation for production if the results are heading the right direction? Uplist? Mhmmm
Comment by 1ottrunner on Dec 11, 2020 7:04am
or...Christmas bonuses and stock options? The dilution has not been taken up by the market and won't be until we know how deep into our pockets they intend to go.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities